‘Ferroptosis’
AI-Driven Molecular Design and Docking of Ferroptosis Inhibitors for Parkinson’s Disease
This study combines AI-driven molecular design with computational docking validation to identify novel ferroptosis inhibitors for Parkinson's disease treatment.
Posted by buchanle on Monday, June 1st, 2026 in May 2026, Drug Discovery, Ferroptosis, Machine learning, Molecular Docking, Parkinson’s disease
Novel Cardioprotective Effects of Ferroptosis Inhibitors in Human-Derived Induced Pluripotent Cardiomyocytes in Response to Hypoxic Conditions
Zileuton and Ferrostatin-1s potential to mitigate hypoxia's impact on calcium metabolism and sarcomere structure.
Posted by buchanle on Tuesday, April 30th, 2024 in May 2024, Calcium Dynamics, Ferroptosis, Hypoxia, Sarcomere